Atlas Trials

Study on Combined Vaccination With SARS-CoV-2 Inactivated Vaccine and Quadrivalent Influenza Vaccine

Clinical trial NCT04801888 · COMPLETED

Trial details

NCT number
NCT04801888
Sponsor
Sinovac Research and Development Co., Ltd.
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
COVID-19Influenza
Start date
2021-03-23
Primary completion
2021-05-28
Enrollment
480

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.